Some witnessed their blood sugar go way down
An analysis of self-funded plans by one of our partners showed that if a 250-person company chooses to cover GLP-1s for weight loss, even assuming a lifetime maximum of $18,000, they can expect to see a total claims increase of 5%
Over 80 weeks, participants who received the highest dose lost an average of 28.3% of their body weight, far exceeding previous benchmarks from other GLP-1 agonists
Fetching molecular profile Retatrutide Mechanism of Action Retatrutide is a synthetic peptide agonist of multiple hormone receptors including GLP-1, GIP, and glucagon receptors
References AL-Mhanna SB, Batrakoulis A, Wan Ghazali WS, et al
Mayo Clinics data has women on tirzepatide plus hormone therapy losing 19.2% of body weight against 14% on tirzepatide alone